GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.

GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 170 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.

GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

0
Network Investigators
0
Trained HQP
0
Funded Projects
0
Network Partners

Latest News

GlycoNet Investigator receives award to advance technologies for ‘Universal Donor’ O type blood

Dr. Stephen Withers is one of nine recipients of the 2020 Innovation to Commercialization Program Award from the Michael Smith Foundation of Health Research.

A better way to freeze stem cells and tissue

The best technological innovations are inspired by nature.

GlycoNet Investigator named to the Order of Canada

Dr. Lori West receives one of Canada’s highest honours to recognize her leadership in organ transplantation and donation.

Network Members

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
Scroll to Top